학술논문
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery
Document Type
Article
Author
Albain, K.S.; Godellas, C.; Yau, C.; Wolf, D.M.; Chien, A.J.; Brown-Swigart, L.; Krings, G.; Chen, Y.Y.; Hirst, G.L.; Singhrao, R.; Buxton, M.; Clennell, J.L.; Matthews, J.B.; Hylton, N.M.; Melisko, M.; Rugo, H.S.; van't Veer, L.J.; Esserman, L.J.; Petricoin, E.F.; Gallagher, R.I.; Wulfkuhle, J.D.; Lang, J.E.; Haddad, T.; Boughey, J.C.; Forero-Torres, A.; Stringer-Reasor, E.; Wallace, A.M.; Blair, S.; Kaplan, H.; Pusztai, L.; Euhus, D.; Nanda, R.; Elias, A.D.; Clark, A.S.; DeMichele, A.M.; Isaacs, C.; Tripathy, D.; Symmans, W.F.; Lu, J.; Yung, R.L.; Potter, D.A.; Yee, D.; Asare, S.M.; Wilson, A.; Asare, A.L.; Sanil, A.; Berry, S.; Berry, D.A.; Perlmutter, J.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 15 February 2024, 30(4):729-740)
Subject
Language
English
ISSN
15573265
10780432
10780432